蛋白质降解剂 - 从thalidomide到新的PROTACs
1Institute of Medical Science, Tokyo Medical University, 6-1-1, Shinjuku, Shinjuku-ku, Tokyo 160-8402, Japan.
Journal of biochemistry
|December 23, 2023
概括
蛋白质降解剂,包括向蛋白质溶解的嵌合体 (PROTACs) 和分子降解剂 (MGDs),已经显著发展. 这篇评论追溯了他们的历史,从thalidomide到影响治疗和生物科学的当前技术.
科学领域:
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
- 药物发现 药物发现 药物发现
背景情况:
- 蛋白质降解剂是快速发展的治疗化合物的类别.
- 存在两种主要类型:蛋白质分解向嵌合体 (PROTACs) 和分子降解剂 (MGDs).
- 已经阐明了MGD的thalidomide的作用机制,确定了cereblon (CRBN) 作为其点.
研究的目的:
- 提供蛋白质降解剂发展的历史概述.
- 要突出从thalidomide到现代 PROTAC 和 MGD 的关键里程碑.
- 讨论蛋白质降解剂对治疗和基本生物学研究的影响.
主要方法:
- 关于蛋白质降解剂研究的历史和最近发展的文献综述.
- 对PROTACs和MGDs分子机制和临床应用的分析.
- 讨论新兴技术和该领域的未来方向.
主要成果:
- thalidomide是一种众所周知的MGD,为了解CRBN介导的降解铺平了道路.
- 几种结合CRBN的MGD (thalidomide,lenalidomide,pomalidomide) 已被批准用于治疗多发性骨髓瘤等疾病.
- 许多PROTAC和MGD正在临床试验中,证明了广泛的治疗潜力.
结论:
- 蛋白质降解剂代表了药物发现和开发的重大进步.
- 从thalidomide到先进的PROTAC的历史进展展示了非凡的科学成就.
- 这些化合物为治疗难治的疾病和促进生物理解提供了新的途径.
相关概念视频
01:07Teratogenicity
2.5K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.5K
01:25Drug Regulation
1.4K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.4K
02:58Regulated Protein Degradation
2.5K
2.5K
01:30Prodrugs
2.6K
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
Prodrugs help overcome...
2.6K
02:11Proteins: From Genes to Degradation
12.3K
Within a biological system, the DNA encodes the RNA, and the nucleotide sequence in the RNA further defines the amino acid sequence in the protein. This is referred to as “The Central Dogma of Molecular Biology” - a term coined by Francis Crick. Central dogma is a firm principle in biology that defines the flow of genetic information within any life form. The two fundamental steps in central dogma are - transcription and translation.
Transcription is the synthesis of RNA...
Transcription is the synthesis of RNA...
12.3K
01:13The Proteasome
847
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
847